Share Issue/Capital Change • Dec 1, 2014
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
PRESS RELEASE
1 December 2014 – 6.00 p.m. – Regulatory Information
The operation was explained in a press release of 23 September 2014:
Following the share merger of 15 September 2014, on his own initiative, Frank De Palmenaer announced an extraordinary transaction. In order to increase the free float and the liquidity, majority shareholder and CEO of ABO-Group Frank De Palmenaer is selling an unspecified part of his participation in the group on or outside the stock exchange between 24 September 2014 and 30 November 2014. After the closure, 90% of the proceeds from the sale are to be introduced into ABO-Group as a capital increase in return for the issue of just one new share of the company.
Thus, between 24 September and 30 November, Frank De Palmenaer is selling 62,916 shares in total on the stock exchange for a total sum of € 585,569.01.
The announced sale by Frank De Palmenaer was given the following objectives, which were also achieved:
increasing the free float of the company share listed on Euronext Brussels by 62,916 shares;
reducing the discrepancy of the intrinsic value and the market value of the company's shares.
As announced in the press release, Frank De Palmenaer asked to introduce 90% of € 585,569.01 or € 527,012.11 in the company in the form of a capital increase in return for the issue of just one share in the company. The share issued following the capital increase described above will have the same rights as the existing shares.
The Board of Directors believes that the capital increase announced now in return for the issue of one share in the company represents the tailpiece of the operation and that it is in the company's and shareholders' interest, because it achieves the following aims together.
The Board of Directors is expected to perform the capital increase before the end of this year, and will use its powers for this within the framework of the permitted capital. Therefore, no extraordinary general meeting must be convened.
1 Relution is a reversed dilution
| Statutory equity | on 30.06.2014 |
Contribution | After capital increase |
|---|---|---|---|
| € 24,755,971.11 | € 527,012.11 | € 25,282,983.22 | |
| Per share | € 2.342 | € 0.050 | € 2.392 |
| Capital increase | Before | Contribution | After |
|---|---|---|---|
| Capital | € 165,963,562.37 |
€ 527,012.11 |
€ 166,490,574.48 |
| Shares | 10,568,734 | 1 | 10,568,735 |
| Equity ratio | Before | Sell | After |
|---|---|---|---|
| F. De Palmenaer | 9,776,104 | -62,916 | 9,713,188 |
| Dilution | 92.50% | -0.6% | 91.90% |
| Overige aandeelhouders | 792,630 | 62,916 | 855,546 |
| Relution | 7.50% | 0.6% | 8.10% |
Frank De Palmenaer Johan Reybroeck CEO ABO-Group NV CFO ABO-Group NV
T +32 (0)496 59 88 99 Derbystraat 255, Maaltecenter Blok G, B-9051 Ghent (SDW), Belgium
This press release is available on our website www.ABO-Group.eu
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.